Jee Suk Chang

Yonsei University

Papers

1

Total Citations

8

H-Index

1

About

Dr. Jee Suk Chang is a radiation oncologist whose research centers on optimizing breast cancer treatment through advanced radiotherapy techniques, with a particular focus on stereotactic accelerated partial breast irradiation (SAPBI). His most-cited work, a 2023 prospective observational cohort study, rigorously evaluated cosmetic outcomes and toxicity in early breast cancer patients undergoing SAPBI, demonstrating that this approach can achieve favorable aesthetic results while minimizing radiation-related side effects. This study, which has garnered 8 citations, contributes to the growing body of evidence supporting less invasive, targeted breast irradiation as a viable alternative to whole-breast radiotherapy. Dr. Chang’s contributions are notable for their emphasis on patient-centered outcomes, balancing oncologic efficacy with quality of life. His research helps refine clinical protocols, potentially reducing treatment burden for early-stage breast cancer patients. Through his work, Dr. Chang advances the field of radiation oncology by providing data that supports the safe implementation of stereotactic techniques, ultimately aiming to improve both survival and survivorship in breast cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Cosmetic Outcome and Toxicity After Stereotactic Accelerated Partial Breast Irradiation in Early Breast Cancer: A Prospective Observational Cohort Study
8 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Yonsei University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago